Here are five quick facts:
1. Stephens has an “overweight” rating on AmSurg stock.
2. The firm’s price objective indicates a possible upside of 18.41 percent from AmSurg’s current price objective.
3. On Monday, AmSurg shares traded down nearly 0.3 percent, hitting $81.92.
4. AmSurg’s market cap is $3.91 billion.
5. The P/E ratio is 33.85.
More articles on surgery centers:
3 new joint venture ASCs — November 2015
Health Republic insurance closure affects 200k people — 4 observations
NY DOH issues final approval for Orchard Park ASC
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
